Panchsheel Organics Limited

PANCHSHEEL

INE316G01019

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 01:38:16 2024-05-08 am EDT			5-day change	1st Jan Change
205 ^INR	+0.29%		+3.07%	+4.57%

Mar. 29	Panchsheel Organics Limited Announces Resignation of Hitesh Singh Parihar as Company Secretary & Compliance Officer	CI
Feb. 14	Panchsheel Organics Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 13, 2024	CI

Panchsheel Organics Limited Announces the Appointment of Gaurang Natavar Patel as Chief Financial Officer

April 29, 2023 at 04:43 am EDT

Panchsheel Organics Limited announced the appointment of Mr. Gaurang Natavar Patel as Chief Financial Officer with effect from April 28, 2023. He has experience of more than 15 years in the field of Accounting and Finance. He is very versatile in the field of Investments and securities.

He has expertise in making financial decisions, managing budgeting processes and capital requests.

Latest news about Panchsheel Organics Limited

Panchsheel Organics Limited Announces Resignation of Hitesh Singh Parihar as Company Secretary & Compliance Officer	Mar. 29	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 13, 2024	Feb. 14	CI
Panchsheel Organics Names CFO	Feb. 13	MT
Panchsheel Organics Limited Announces CFO Changes	Feb. 13	CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Panchscheel Organics Board Declares Interim Dividend for Fiscal 2024	Nov. 21	MT
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 10	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 10, 2023	Nov. 10	CI
Panchsheel Organics Limited Approves Dividend	23-08-16	CI
Panchsheel Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Panchsheel Organics Limited Recommends Final Dividend for the Financial Year 2022-23	23-05-30	CI
Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-30	CI
Panchsheel Organics Limited Announces the Appointment of Hitesh Singh Parihar as Company Secretary and Compliance Officer	23-04-29	CI
Panchsheel Organics Limited Announces the Appointment of Gaurang Natavar Patel as Chief Financial Officer	23-04-29	CI
Panchsheel Organics Limited Announces Demise of Chandrakant Shah, Chief Financial Officer	23-04-10	CI
Panchsheel Organics Limited Declares Interim Dividend for the Year Ending March 31, 2023, Payable on or Before March 14, 2023	23-02-13	CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Panchsheel Organics Limited Announces Resignation of Nikhil Borana as Company Secretary & Compliance Officer	23-02-04	CI
Panchsheel Organics Secures Land for Fermentation Facility in Indore, India	22-11-23	MT
Panchsheel Organics Limited Receives Allotment of Land in DMIC Vikram Udyogpuri Biotech Park Near Indore	22-11-23	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 14, 2022	22-11-14	CI
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Panchsheel Organics Limited announced that it has received INR 388.909868 million in funding from a group of investors	22-09-07	CI
Panchsheel Organics Limited Approves Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before September 22, 2022	22-08-23	CI
Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-30	CI

Chart Panchsheel Organics Limited

Duration

Period

More charts

Company Profile

Panchsheel Organics Limited is an India-based company engaged in manufacturing and exporting active pharmaceutical ingredients (APIs), intermediates and finished formulations (both human and veterinary). Its specialties include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression granules, fitness and healthcare, and product development and testing laboratory. The Company offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone, Leflunomide, and others. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and others. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder, Phytosterol, and others.

Sector

Pharmaceuticals

Calendar

2024-05-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PANCHSHEEL ORGANICS LIMITED	+4.57%	28.85M
ELI LILLY AND COMPANY	+33.43%	700B
NOVO NORDISK A/S	+26.43%	569B
JOHNSON & JOHNSON	-5.12%	358B
MERCK & CO., INC.	+19.59%	330B
ABBVIE INC.	+4.89%	287B
ASTRAZENECA PLC	+14.32%	236B
NOVARTIS AG	+5.79%	202B
ROCHE HOLDING AG	-9.49%	197B
AMGEN INC.	+4.26%	161B

Other Pharmaceuticals